NRX Pharmaceuticals NRXP
NASDAQ NRXP
$2.85 -0.07 (-2.40%)
At close: Oct 1, 2026 · 4:00 PM EDT

NRX Pharmaceuticals (NRXP) EBT Margin (2025 - 2026)

Updated

NRX Pharmaceuticals (NRXP) posted EBT Margin of -612.08% for Q2 2026, down 160.26 percentage points from the prior quarter.

Analysis

NRX Pharmaceuticals (NRXP) EBT Margin (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBT Margin at NRX Pharmaceuticals was -613.60%; for FY2025, it came in at -1378.20%.

  • Quarterly EBT Margin has run from a low of -1661.98% in Q3 2025 to a high of -451.82% in Q1 2026 over five years.
  • According to Business Quant data, EBT Margin for the three prior quarters was -451.82% (Q1 2026), -538.25% (Q4 2025) and -1661.98% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 26.66%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 25.18%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -4.11%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 29.63%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 18.19%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 27.53%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -131.41%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -4.34%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 41.75%
10 NRX Pharmaceuticals 126.02 Mn 77.61 Mn 426,000.00 -612.08%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -612.08%
Mar 31, 2026 -451.82%
Dec 31, 2025 -538.25%
Sep 30, 2025 -1,661.98%
API Access

NRX Pharmaceuticals EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=NRXP&period=max&api_key=YOUR_API_KEY